Table 3 Timing of CA contrasting NSTEMI patients with final diagnosis after the first versus the second cTn control
Time of CA | Overall | Site I | Site II | p value |
|---|---|---|---|---|
NSTEMI ensured by the 1st control (h) | ||||
Overall | 20.5 h (11.6–45.3 h) | 22.0 h (12.3–46.5 h) | 20.0 h (10.8–43.5 h) | 0.55 |
Group (a) | 22.0 h (11.0–49.8 h) | 23.5 h (12.1–51.1 h) | 20.0 h (10.0–40.5 h) | 0.35 |
Group (b) | 15.0 h (7.0–53.8 h) | NA | 15.0 h (7.0–53.8 h) | NA |
Group (c) | 21.0 h (13.5–35.0 h) | 21.0 h (13.0–30.0 h) | 21.3 h (15.0–63.9 h) | 0.75 |
NSTEMI ensured by the 2nd control (h) | ||||
Overall | 22.3 h (20.5–28.9) | 10.0 h; 27.0 h | 22.3 h (20.5–28.9 h) | Omitted to due remaining small sample size |
Group (a) | 20.0 h (15.5–22.0 h) | 10.0 h | 21.0 h (18.9–38.5 h) | |
Group (b) | 22.5 h; 31.0 h | NA | 22.5 h; 31.0 h | |
Group (c) | – | 27.0 h | – | |